ArticleEuropean heart journal. Case reports2025
Re-sheathing failure with Navitor during transcatheter aortic valve implantation: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Self-expanding valves used in transcatheter aortic valve implantation (TAVI) are designed to allow recapture and repositioning, facilitating optimal placement and mitigating conduction disturbances and paravalvular leakage. Here, we present a rare case in which the Navitor (Abbott Structural Heart, Santa Clara, CA, USA) could not be recaptured. Case summary: An 81-year-old Japanese woman with very severe aortic stenosis and a massively calcified nodule at the non-coronary cusp (NCC) underwent TAVI with a 25 mm Navitor valve. During the initial deployment attempt, non-uniform expansion (NUE) was observed on the NCC side when the valve was 80% deployed. An attempt was made to recapture and reposition the valve, but the delivery system capsule failed to fully re-sheath the prosthesis, leaving approximately one-third of the valve outside the capsule and preventing complete recapture. The Navitor was promptly redeployed while still within the basal ring. Following redeployment, the NUE resolved, and the valve was successfully positioned 3 mm below the basal ring on the NCC side and 4 mm below the left coronary cusp. We hypothesized that interference between the capsule tip and the calcified nodule on the NCC leaflet inhibited the re-sheathing process. Conclusion: This report documents a rare complication involving the failure to recapture the Navitor valve. In cases with large calcified nodules on the leaflet, caution is essential during the re-sheathing process. We strongly recommend re-deploying the prosthesis rather than attempting to remove it from the basal ring to minimize procedural risks and ensure proper valve placement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.